Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer von George, Mridula A., Qureshi, Sadaf, Omene, Coral, Toppmeyer, Deborah L., Ganesan, Shridar

Volltext

Clinical efficacy of PARP inhibitors in breast cancer von Pandya, Karan, Scher, Alyssa, Omene, Coral, Ganesan, Shridar, Kumar, Shicha, Ohri, Nisha, Potdevin, Lindsay, Haffty, Bruce, Toppmeyer, Deborah L., George, Mridula A.

Volltext

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial) von Tung, Nadine, Arun, Banu, Hacker, Michele R, Hofstatter, Erin, Toppmeyer, Deborah L, Isakoff, Steven J, Borges, Virginia, Legare, Robert D, Isaacs, Claudine, Wolff, Antonio C, Marcom, Paul Kelly, Mayer, Erica L, Lange, Paulina B, Goss, Andrew J, Jenkins, Colby, Krop, Ian E, Winer, Eric P, Schnitt, Stuart J, Garber, Judy E

Volltext

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial von Albain, Kathy S, Gray, Robert J, Makower, Della F, Faghih, Amir, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Wood, William C, Keane, Maccon M, Gomez, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W, Sparano, Joseph A

Volltext

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer von HAFFTY, Bruce G, QIFENG YANG, REISS, Michael, KEARNEY, Thomas, HIGGINS, Susan A, WEIDHAAS, Joanne, HARRIS, Lyndsay, HAIT, Willam, TOPPMEYER, Deborah

Volltext

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Perez, Edith A, Olson, John A, Zujewski, JoAnne, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Atkins, James N, Berenberg, Jeffrey L, Sledge, George W

Volltext

Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer von Toppmeyer, Deborah L., Press, Michael F.

Volltext

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer von Sparano, Joseph A, Gray, Robert J, Ravdin, Peter M, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W

Volltext

Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow von Kinney, Anita Y, Walters, Scott T, Lin, Yong, Lu, Shou-En, Kim, Arreum, Ani, Julianne, Heidt, Emily, Le Compte, Circe J G, O'Malley, Denalee, Stroup, Antoinette, Paddock, Lisa E, Grumet, Sherry, Boyce, Tawny W, Toppmeyer, Deborah L, McDougall, Jean A

Volltext

SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center von Shah, Mansi R., Jan, Imraan, Johns, Jeremy, Singh, Kuldip, Kumar, Pallavi, Belarmino, Norma, Saggiomo, Kara J., Hayes, Carolyn, Washington, Kimyatta, Toppmeyer, Deborah L., Haffty, Bruce G., Libutti, Steven K., Evens, Andrew M.

Volltext

Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes von Mehta, Madhura S, Dolfi, Sonia C, Bronfenbrener, Roman, Bilal, Erhan, Chen, Chunxia, Moore, Dirk, Lin, Yong, Rahim, Hussein, Aisner, Seena, Kersellius, Romona D, Teh, Jessica, Chen, Suzie, Toppmeyer, Deborah L, Medina, Dan J, Ganesan, Shridar, Vazquez, Alexei, Hirshfield, Kim M

Volltext

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker von Qureshi, Sadaf, Chan, Nancy, George, Mridula, Ganesan, Shridar, Toppmeyer, Deborah, Omene, Coral

Volltext

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer von Gorshein, Elan, Matsuda, Kant, Riedlinger, Gregory, Sokol, Levi, Rodriguez-Rodriguez, Lorna, Eladoumikdachi, Firas, Grandhi, Miral, Ganesan, Shridar, Toppmeyer, Deborah L., Potdevin, Lindsay, Toomey, Kathleen, Hirshfield, Kim M., Chan, Nancy

Volltext

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma von Bjørklund, Sunniva Stordal, Panda, Anshuman, Kumar, Surendra, Seiler, Michael, Robinson, Doug, Gheeya, Jinesh, Yao, Ming, Alnæs, Grethe I. Grenaker, Toppmeyer, Deborah, Riis, Margit, Naume, Bjørn, Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Ganesan, Shridar, Bhanot, Gyan

Volltext

HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment von Gandarillas, Sophia, Newland, Elizabeth Schoenberg, Toppmeyer, Deborah, Stephenson, Ryan, Denzin, Lisa, Dasgeb, Bahar

Volltext

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner von BOND, Gareth L, HIRSHFIELD, Kim M, TOPPMEYER, Deborah, OFFIT, Kenneth, LEVINE, Arnold J, KIRCHHOFF, Tomas, ALEXE, Gabriella, BOND, Elisabeth E, ROBINS, Harlan, BARTEL, Frank, TAUBERT, Helge, WUERL, Peter, HAIT, William

Volltext

Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients von Tian, Sibo, Hirshfield, Kim M, Jabbour, Salma K, Toppmeyer, Deborah, Haffty, Bruce G, Khan, Atif J, Goyal, Sharad

Volltext

Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance) von Sharma, Manish R., Mehrotra, Shailly, Gray, Elizabeth, Wu, Kehua, Barry, William T., Hudis, Clifford, Winer, Eric P., Lyss, Alan P., Toppmeyer, Deborah L., Moreno‐Aspitia, Alvaro, Lad, Thomas E., Velasco, Mario, Overmoyer, Beth, Rugo, Hope S., Ratain, Mark J., Gobburu, Jogarao V.

Volltext

Adapting and implementing breast cancer follow-up in primary care: protocol for a mixed methods hybrid type 1 effectiveness-implementation cluster randomized study von Fadem, Sarah J, Crabtree, Benjamin F, O'Malley, Denalee M, Mikesell, Lisa, Ferrante, Jeanne M, Toppmeyer, Deborah L, Ohman-Strickland, Pamela A, Hemler, Jennifer R, Howard, Jenna, Bator, Alicja, April-Sanders, Ayana, Kurtzman, Rachel, Hudson, Shawna V

Volltext

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients von Sayan, Mutlay, Abou Yehia, Zeinab, Gupta, Apar, Toppmeyer, Deborah, Ohri, Nisha, Haffty, Bruce G

Volltext